The role of insulin-like growth factor binding proteins in development

Reviews in Endocrine and Metabolic Disorders

Volumn 6, Issue 3, 2005, Pages 189-198

  Pell, J M ^a   Salih, D A M ^a   Cobb, L J ^a   Tripathi, G ^a   Drozd, A ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Embryo; Growth; Insulin like growth factors; Knockout; Transgenic

Indexed keywords

SOMATOMEDIN BINDING PROTEIN;

GENE OVEREXPRESSION; HUMAN; IN VIVO STUDY; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; EMBRYO; EVOLUTION, MOLECULAR; GROWTH; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MODELS, GENETIC; SOMATOMEDINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSGENES;

EID: 24644515821     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-005-3050-z     Document Type: Review

References (91)

1. Vilmos P, Graudenz K, Hegedus Z, Marsh JL. The Twisted gastrulation family of proteins, together with the IGFBP and CCN families, comprise the TIC superfamily of cysteine rich secreted factors. J Clin Pathol 2001;54:317-323.
2. Ross JR, Shimmi O, Vilmos P, Pteryk A, Kim H, Gaudenz K, Hermanson S, Ekker SC, O'Connor MB, Marsh JL. Twisted gastrulation is a conserved extracellular BMP antagonist. Nature 2001;410:479-483.
3. Grotendorst GR, Lau LF, Perbal B. CCN proteins are distinct from and should not be considered members of the insulin-like growth factor binding protein superfamily. Endocrinology 2000;141:2254-2256.
4. Kelley KM, Schmidt KE, Berg L, Sak K, Galima MM, Gillespie C, Balogh L, Hawayek A, Reyes JA, Jamison M. Comparative endocrinology of the insulin-like growth factor-binding proteins. J Endocrinol 2002;175:3-18.
5. Pierce SB, Costa M, Wisotsky R, Dvadhar S, Homburger SA, Buchman AR, Ferguson KC, Heller J, Platt DM, Pasquinelli AA, Liu LX, Doberstein SK, Ruvkun G. Regulation of DAF-2 receptor signalling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 2001;15:672-686.
6. Garofalo RS. Genetic analysis of insulin signalling in Drosophila. Trends Endocrinol Metab 2002;13:156-163.
7. Dehal P, Yutaka Satou, Robert K. Campbell, Jarrod Chapman, Bernard Degnan, Anthony De Tomaso, Brad Davidson, Anna Di Gregorio, Maarten Gelpke, David M. Goodstein, Naoe Harafuji, Kenneth EM Hastings, Isaac Ho, Kohji Hotta, Wayne Huang, Takeshi Kawashima, Patrick Lemaire, Diego Martinez, Ian A. Meinertzhagen, Simona Necula, Masaru Nonaka, Nik Putnam, Sam Rash, Hidetoshi Saiga, Masanobu Satake, Astrid Terry, Lixy Yamada, Hong-Gang Wang, Satoko Awazu, Kaoru Azumi, Jeffrey Boore, Margherita Branno, Stephen Chin-bow, Rosaria DeSantis, Sharon Doyle, Pilar Francino, David N. Keys, Shinobu Haga, Hiroko Hayashi, Kyosuke Hino, Kaoai S. Imai, Kazuo Inaba, Shungo Kano, Kenji Kobayashi, Mari Kobayashi, Byung-In Lee, Kazuhiro W. Makabe, Chitra Manohar, Giorgio Matassi, Monica Medina, Yasuaki Mochizuki, Steve Mount, Tomomi Morishita, Sachiko Miura, Akie Nakayama, Satoko Nishizaka, Hisayo Nomoto, Fumiko Ohta, Kazuko Oishi, Isidore Rigoutsos, Masako Sano, Akane Sasaki, Yasunori Sasakura, Eiichi Shoguchi, Tadasu Shin-i, Antoinetta Spagnuolo, Didier Stainier, Miho M. Suzuki, Olivier Tassy, Naohito Takatori, Miki Tokuoka, Kasumi Yagi, Fumiko Yoshizaki, Shuichi Wada, Cindy Zhang, P. Douglas Hyatt, Frank Larimer, Chris Detter, Norman Doggett, Tijana Glavina, Trevor Hawkins, Paul Richardson, Susan Lucas, Yuji Kohara, Michael Levine, Nori Satoh, and Daniel S. Rokhsar: the draft genome of Ciona intesintalis: Insights into chordate and vertebrate origins. Science 2002;298:2157-2167.
8. Guo Z-Y, Shen L, Gu W, Wu A-Z, Ma J-G, Feng Y-M. In vitro evolution of amphioxus insulin-like peptide to mammalian insulin. Biochemistry 2002;41:10603-10607.
9. Chan SJ, Cao Q-P, Steiner DF. Evolution of the insulin superfamily: Cloning of a hybrid insulin/insulin-like growth factor cDNA from amphioxus. Proc Natl Acad Sci USA 1990;87:9319-9323.
10. Wang S, Guo Z-Y, Shen L, Zhang Y-J, Feng Y-M. Refolding of Amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavoir of insulin and insulin-like growth factor 1. Biochemistry 2003;42:9687-9693,
11. Nagamatsu S, Chan SJ, Falkmer S, Steiner DF. Evolution of the insulin gene superfamily; sequence of a preproinsulin-like growth factor cDNA from the Atlantic hagfish. J Biol Chem 1991;266:2397-2402.
12. Leibush BN, Lappova YL, Bondareva VM, Chistyacova OV, Gutierrez J, Plisetskaya EM. Insulin-family peptide-receptor interaction at the early stage of vertebrate evolution. Comp Biochem Physiol B 1998;121:57-63.
13. Duguay SJ, Chan SJ, Mommsen TP, Steiner DF. Divergence of insulin-like growth factors I and II in the elasmobranch, Squalus acanthias. FEBS Lett 1995;371:69-72.
14. Killian JK, Nolan CM, Stewart N, Munday BL, Andersen NA, Nicol S, Jirtle RL. Monotreme IGF2 expression and ancestral origin of genomic imprinting. J Exp Zoo 2001;291:205-212.
15. Killian JK, Byrd JC, Jirtle JV, Munday BL, Stiskopf MK, MacDonald RG, Jirtle RL. M6P/IGF2R imprinting evolution in mammals. Molec Cell 2000;5:707-716.
16. Lillian JK, Nolan CM, Wylie AA, Li T, Vu TH, Hoffman AR, Jirtle RL. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Human Molec Genet 2001;10:1721-1728.
17. Williams EJB, Pal C, Hurst LD. The molecular evolution of signal peptides. Gene 2000;253:313-322.
18. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-854.
19. Clemmons DR. Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr Rev 2001;22:800-817.
20. Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends Endcrinol Metab 2003;14:176-181.
21. Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM. Role of N-and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 2004;279:53232-53240.
22. Imai Y, Busby WH, Clarke JB, Horvitz G, Rees C, Clemmons DR. Protease resistant IGFBP-5 inhibits actions of IGF-I on porcine smooth muscle cells. J Clin Invest 1997;100:2596-2605.
23. Andress DL, Loop SM, Zapf J, Kiefer MC. Carboxy-truncated insulin-like growth factor-binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 1993;195:25-30.
24. Kajantie E, Dunkel L, Rutanen E-M, Sappälä M, Koistinen R, Sarnesto A, Andersson S. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endcrinol Metab 2002;87:2171-2179.
25. 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993;90:10553-10557.
26. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, Baxter RC. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin β subunit. J Biol Chem 2000;275:23462-23470.
27. Lee KW, Ma L, Yan X, Liu B, Zhang XK, Cohen P. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J Biol Chem 2005;280:16942-16948.
28. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ. Mohan: insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 2002;277:12053-12060.
29. Xu Q, Li S, Zhao Y, Maures TJ, Yin P, Duan C. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells. Circ Res 2004;94:E46-E54.
30. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997;272:12181-12188.
31. Cobb LJ, Salih DAM, Gonzalez I, Tripathi G, Carter EJ, Lovett F, Holding C, Pell JM. Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J Cell Sci 2004;117:1737-1746.
32. Butt AJ, Fraley KA, Firth SM, Baxter RC. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 2002;143:2693-2699.
33. Leal SM, Liu QJ, Huang SS, Huang JS. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 272:20572-20576.
34. Andress DL. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am J Physiol 1998;274:E744-E750.
35. Singh B, Charkowicz D, Mascarenhas D. Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. J Biol Chem 2004;279:477-487.
36. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 2004;279:469-76.
37. Parker A, Rees C, Clarke JB, Busby WH, Clemmons DR. Binding of insulin-like growth factor binding protein-5 to smooth muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell 1998;9:2383-2392.
38. Telford NA, Hogan A, Franz CR, Schulz GA. Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells. Mol Reprod Dev 1990;27:81-92.
39. Lee JE, Pintar JE, Efstratiadis A. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 1990;110:151-159.
40. Streck RD, Pintar JE. The embryonic pattern of rat insulin-like growth factor-I gene expression suggests a role in induction and early growth of the liver. Endocrinology 1992;131:2030-2032.
41. Pintar JE, Cerro, Streck R, Wood T, Rogler L, Green B, Grewall A. Expression and function of IGFBPs during rodent development. In: RC Baxter, PD Gluckman, RG Rosenfeld eds The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier Science BV 1999;253-261.
42. Cheng HL, Shy M, Feldman EL. Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. Endocrinology 1999;140:4478-4485.
43. Thraikill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, Fowlkes JL. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 1995;136:3527-3533.
44. James PL, Jones SB, Busby WH Jr, Clemmons DR, Rotwein P. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J Biol Chem 1993;268:22305-22312.
45. Green BN, Jones SB, Streck RD, Wood TL, Rotwein P, Pintar JE. Distinct patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology 1994;134:954-962.
46. Allan GJ, Flint DJ, Darling SM, Geh J, Patel K. Altered expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins-2 and -5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity. Ant Embryol Berl 2000;202:1-11.
47. Tonner E, Barber MC, Travers MT, Logan A, Flint DJ. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 1997;138:5101-5107.
48. Allar MA, Wood TL. Expression of the insulin-like growth factor binding proteins during postnatal development of the during mammary gland. Endocrinology 2004;145:2467-2477.
49. van Kleffens M, Groffen CAH, Dits NJF, Lindenbergh-Kortleve DJ, Schuller AGP, Bradshaw SL, Pintar JE, Zwarthoff EC, Drop SLS, van Neck JW. Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to-6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo. Endocrinology 1999;140:5944-5952.
50. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998;42:955-976.
51. Nayak NR, Giudice LC. Comparitive biology of the IGF system in endometrium, deciduas, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 2003;24:281-296.
52. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945-948.
53. Burns JL, Hassan AB. Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. Development 2001;128:3819-3830.
54. Han VKM, Bassett N, Walton J, Challis JRG. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta at the fetal-maternal interface. J Clin Endocrinol Metab 1996;81:2680-2693.
55. Hamilton GS, Lysiak JJ, Han VKM, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res 1998;244:147-156.
56. Wood TL, Rogler LE, Czick ME, Schuller AGP, Pintar JP. Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. Mol Endocrinol 2000;14:1472-1482.
57. Pintar J, Hoang B, Ning Y, Schuller A. Single and multiple knockouts of the IGFBPs. Program of the 83rd Annual Meeting of the Endocrine Society, Denver, 2001;S33-1.
58. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fchtbauer E-M, Oxvig C, van Deursen J. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004;131:1187-1194.
59. Leu JI, Crissey MS, Craig LE, Taub R. Impaired hepatic DNA synthetic response posthepatectomy in insulin-like growth factor binding protein-1 deficient mice with defects in C/EBPfl and MAPK/ERK regulation. Mol Cell Biol 2003;23:1251-1259.
60. Leu JI, Crissey AS, Taub R. Massive hepatic apoptosis associated with TFG-β1 activation after Fas ligand teatment of IGF binding protein-1-deficient mice. J Clin Invest 2003;111:129-139.
61. Duan C, Ding J, Li Q, Tsai W, Pozios K. Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish. Proc Natl Acad Sci USA 1999;96:15274-15279.
62. Maures TJ, Duan C. Structure, developmental expression, and physiological regulation of zebrafish IGF binding protein-1. Endocrinology 2002;143:2722-2731.
63. Kajimura S, Aida K, Duan C. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci USA 2005;102:1240-1245.
64. Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Sues LF, Irwin JC, Powel DR, Giaccia AJ, Giudice LC. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 1998;95:10188-10193.
65. Li Y, Xiang J, Duan C. Insulin-like growth factor-binding protein-3 plays an important role in regulating pharyngeal skeleton and inner ear formation and differentiation. J Biol Chem 2005;280:3613-3620.
66. Silha JV, Murhpy LJ. Minireview: insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 2002;143:3711-3714.
67. Murphy LJ, Seneviratne C, Moreira P, Reid R. Enhanced expression of insulin-like frowth factor binding protein-1 in the fasted rat: the effects of insulin and growth hormone administration. Endocrinology 1991;128:689-696.
68. Rajkumar K, Krsek M, Dheen T, Murphy LJ. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 1996;98:1818-1825.
69. Rajkumar K, Murphy LJ. Enhanced gluconeogenesis and hepatic insulin resistance in insulin-like growth factor binding protein-1 transgenic mice. Biochim Biophys Acta 1999;1426:491-497.
70. Rajkumar K, Barron D, Lewitt MS, Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995;136:4029-4034.
71. Gay E, Seurin D, Babajko S, Doublier S, Cazillis M, Binoux M. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 1997;138:2937-2947.
72. Huang H, Rajkumar K, Murphy LJ. Reduced fecundity in insulin-like growth factor-binding protein-1 transgenic mice. Biol Reprod 1997;56:284-289.
73. Froment P, Staub, Hembert S, Pisselet C, Magistrini M, Delaleu B, Seurin D, Levine JE, Johnson L, Binoux M, Monget P. Reproductive abnormalities in human insulin-like growth factor-binding protein-1 transgenic male mice. Endocrinology 2004;145:2080-2091.
74. Crossey PA, Lillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein transgenic mice. J Clin Invest 2002;110:411-418.
75. Hoeflich A, Wu M, Mohan S, Föll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduced postnatal body weight gain. Endocrinology 1999;140:5488-5496.
76. Hoeflich A, Nedbal S, Blum W, Erhard M, Lahm H, Brem G, Kolb HJ, Wanke R, Wolf E. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 2001;142:1889-1898.
77. Modric T, Silha JV, Shi Z, Gui Y, Suwanichkul A, Durham SK, Powell DR, Murphy LJ. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 2001;142:1958-1967.
78. 81-mutant insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) in transgenic mice. Endocrinology 2005;146:1523-1531.
79. Wang J, Niu W, Witte DP, Chernausek SD, Nikifrov YE, Clemens TL, Sharifi B, Strauch AR, Fagin JA. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 1998;139:2605-2614.
80. Zhang M, Smith EP, Kuroda H, Banach W, Chernausek S, Fagin JA. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J Biol Chem 2002;21285-21290.
81. Zhou R, Flaswinkel H, Schneider MR, Lahm H, Hoeflich A, Wanke R, Wolf W. Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice. J Mol Endocrinol 2004;32:349-364.
82. Salih DAM, Tripathi G, Holding C, Szestak TAM, Gonzalex MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM. Insulin-like growth factor-binding protein-5 (Igfbp5) compromises survival, growth, muscle development and fertility in mice. Proc Natl Acad Sci USA 2004;101:4314-4319.
83. Salih DAM, Mohan S, Kasukawa Y, Tripathi G, Lovett FA, Anderson NF, Carter EJ, Wergedal JE, Baylink DJ, Pell JM. Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146:931-940, 2004.
84. Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E. Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 2002;143:3955-3962.
85. Durant D, Pereira R, Stadmeyer L, Canalis E. Transgenic mice expressing selected insulin-like growth factor-binding protein-5 fragments do not exhibit enhanced bone formation. Growth Horm IGF Res 2004;14:319-327.
86. Butt AJ, Dickson KA, McDougall F, Baxter RC. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cell in vitro and in vivo. J Biol Chem 2003;278:29676-29685.
87. Bienvenu G, Suerin D, Grellier P, Froment P, Baudrimont M, Monget P, le Bouc Y, Babajko S. Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproductive abnormalities. Endocrinology 2004;145:2412-2420.
88. Miyakshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice bt increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 2001;142:2641-2648.
89. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S. Evidence that IGFBP-5 functions as a growth factor. J Clin Invest 2001;107:73-81.
90. Pera EM, Wessely O, Li S-Y, De Robertis EM. Neural and head induction by insulin-like growth factor signals. Dev Cell 1:655-665.
91. Holzenberger M, Kappeler L, de Magalhaes Filho C. IGF-I signaling and aging. Exp Gerontol 2004;39:1761-1764.